OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Enhancing these processes involves adjusting various parameters, including cell line engineering, media ingredients, and bioreactor settings. A key goal is to increase antibody yield while minimizing production costs